|
Market Closed -
NYSE
21:00:00 13/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 2.360 USD | -9.92% |
|
-3.28% | +31.11% |
| 08-12 | Protalix BioTherapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 08-12 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 190M | - | - | |||
| 1,078B | |||||
| 632B | - | - | - | ||
| 443B | |||||
| 356B | |||||
| 289B |
Select your edition
All financial news and data tailored to specific country editions
